| Name | Title | Contact Details |
|---|---|---|
Jon Danielson |
Director Information Technology Security | Profile |
We`re FinThrive and we believe revenue management technology will drive the future of healthcare. We pave the way for a healthcare system that ensures every transaction and patient experience is addressed holistically. FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we`re advancing the healthcare economy.
Valu-med Pharmacy Inc is a Dalton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Auburn Nursing Home was founded in 1963 by Frank L. DeFurio, M.D. and Charles B. Richards, M.D. in response to a community need for long term care beds. Auburn Nursing Home opened it doors to the Community on December 1, 1964. Auburn Nursing Home still
Over the years we have always placed the needs of those we serve as our highest priority. We have earned a reputation for providing excellent state-of-the art medical care in a family-centered, healing environment.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.